Field experience with a single intravenous injection of marbofloxacin 16% in lactating dairy cows with acute clinical mastitis.

The article discusses research which investigated the tolerance of marbofloxacin following administration to lactating dairy cows suffering from acute clinical mastitis. Topics covered include the dosage of marbofloxacin given to the cows via intravenous injection, the microbiological examination conducted on the milk of the cows and the decline in the rectal temperature during time course of the target disease. Also mentioned are the side effects observed after injection.